Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NEO-REEDUC - Mixed Reality for Motor Rehabilitation: a Prospective, Multicenter, Controlled, Randomized, Open Study.

NCT07063810 is registered in ClinicalTrials.gov with Slb Pharma as lead sponsor.

NCT NCT07063810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07063810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NEO-REEDUC - Mixed Reality for Motor Rehabilitation: a Prospective, Multicenter, Controlled, Randomized, Open Study.
Lead sponsor
Slb Pharma
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2025
Completion date
April 17, 2026
Enrollment
76 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

brain diseases, cerebral anoxia, cerebral palsy, head trauma, ischemic stroke, multiple sclerosis, neurological conditions, parkinson disease (pd)